G-Rex was designed for predictable, efficient, and scalable cell expansion. It enables parallel patient processing and can produce the large numbers of cells needed for cell-based therapeutics, from preclinical through commercial scale manufacturing.

G-Rex bioreactors eliminate media exchanges and the complex and expensive hardware required in integrated systems.

With one G-Rex bioreactor per patient and a small footprint per bioreactor, you can serve a high volume of patients in parallel—potentially treating 10,000 patients a year in 8x less space than conventional bioreactors.

G-Rex cell culture bioreactors are offered with varying footprints and media fill volumes. The portfolio is designed to accommodate the diverse needs associated with cell therapy manufacturing, supporting small scale research protocols, RUO and open systems all the way through commercial scale manufacturing, GMP and closed-system.